Filament Health Completes IBEX011 Extraction and Begins Stability Testing
Rhelion Life Sciences said its wholly owned subsidiary completed a new extraction of the naturally derived ibogaine drug candidate and commenced stability testing.
Related stories
Enerjisa Enerji Q3 net profit rises to 3.8 billion lira
Net profit was 958.7 million lira a year earlier.
M impact | EQUITY | Nov 02, 2026, 03:44 PM UTC
Enerjisa Enerji reports Q3 revenue
Revenue was lower than in the same period last year.
M impact | EQUITY | Nov 02, 2026, 03:40 PM UTC
Enerjisa Enerji Reports Q3 Revenue of 75.8 Billion Lira
Q3 revenue was 75.8 billion lira, versus 78.8 billion lira a year earlier.
M impact | EQUITY | Nov 02, 2026, 03:40 PM UTC
Reliance Rally and LTCG Rollback Proposal Lift Indian Stocks Nearly 2%
Reliance Industries shares had their best day since 2020, while optimism about a possible rollback of long-term capital gains tax for foreign investors accompanied gains of nearly
M impact | EQUITY | Nov 02, 2026, 03:40 PM UTC
Macquarie Focused Access Fund Launches $281.42 Million Tender Offer
M impact | EQUITY | Nov 02, 2026, 03:39 PM UTC
Loar jumps ahead of expected S&P SmallCap 600 inclusion
Loar Holdings is expected to join the S&P SmallCap 600 on Monday.
L impact | EQUITY | Nov 02, 2026, 03:39 PM UTC